97.61
Schlusskurs vom Vortag:
$98.73
Offen:
$99.49
24-Stunden-Volumen:
400.54K
Relative Volume:
0.56
Marktkapitalisierung:
$5.49B
Einnahmen:
$1.33B
Nettoeinkommen (Verlust:
$120.04M
KGV:
47.61
EPS:
2.05
Netto-Cashflow:
$172.71M
1W Leistung:
+5.10%
1M Leistung:
+6.05%
6M Leistung:
-4.00%
1J Leistung:
+20.76%
Merit Medical Systems Inc Stock (MMSI) Company Profile
Firmenname
Merit Medical Systems Inc
Sektor
Telefon
(801) 253-1600
Adresse
1600 WEST MERIT PARK WAY, SOUTH JORDAN, UT
Vergleichen Sie MMSI mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
MMSI
Merit Medical Systems Inc
|
97.61 | 5.49B | 1.33B | 120.04M | 172.71M | 2.05 |
![]()
ISRG
Intuitive Surgical Inc
|
563.95 | 190.13B | 8.71B | 2.48B | 1.75B | 6.82 |
![]()
ALC
Alcon Inc
|
93.25 | 48.17B | 9.91B | 1.02B | 665.00M | 2.05 |
![]()
BDX
Becton Dickinson Co
|
175.34 | 47.86B | 20.87B | 1.50B | 2.59B | 5.24 |
![]()
RMD
Resmed Inc
|
247.65 | 35.48B | 5.02B | 1.31B | 1.56B | 8.91 |
![]()
COO
The Cooper Companies, Inc.
|
81.76 | 16.11B | 3.90B | 392.30M | 288.10M | 1.95 |
Merit Medical Systems Inc Stock (MMSI) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-03-28 | Eingeleitet | JP Morgan | Overweight |
2024-12-11 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
2024-06-28 | Eingeleitet | Robert W. Baird | Outperform |
2024-04-11 | Eingeleitet | CL King | Buy |
2024-02-07 | Eingeleitet | BofA Securities | Neutral |
2023-12-21 | Hochstufung | Canaccord Genuity | Hold → Buy |
2022-12-20 | Herabstufung | Canaccord Genuity | Buy → Hold |
2021-01-05 | Hochstufung | Needham | Hold → Buy |
2020-09-28 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
2020-02-25 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
2020-02-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
2019-12-12 | Herabstufung | Wells Fargo | Market Perform → Underperform |
2019-09-24 | Eingeleitet | Oppenheimer | Outperform |
2019-09-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
2019-07-26 | Herabstufung | Needham | Buy → Hold |
2019-07-26 | Herabstufung | Wells Fargo | Outperform → Market Perform |
2018-10-02 | Bestätigt | Needham | Buy |
2018-08-07 | Herabstufung | BofA/Merrill | Buy → Underperform |
2018-07-24 | Bestätigt | Needham | Buy |
2018-06-01 | Bestätigt | Needham | Buy |
2018-05-18 | Bestätigt | SunTrust | Buy |
2018-04-26 | Bestätigt | Needham | Buy |
2018-04-20 | Eingeleitet | Needham | Buy |
2018-03-01 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
2017-08-28 | Herabstufung | Raymond James | Strong Buy → Outperform |
2017-07-20 | Eingeleitet | BofA/Merrill | Buy |
2017-06-20 | Eingeleitet | SunTrust | Buy |
2017-04-05 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Merit Medical Systems Inc Aktie (MMSI) Neueste Nachrichten
Merit Medical Systems' (NASDAQ:MMSI) Returns On Capital Are Heading Higher - Yahoo Finance
MMSI Q1 Earnings Call: Tariff Headwinds Offset by Organic Growth and Strong Product Performance - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Merit Medical Systems, Inc. (MMSI) - ACCESS Newswire
We Take A Look At Why Merit Medical Systems, Inc.'s (NASDAQ:MMSI) CEO Has Earned Their Pay Packet - simplywall.st
Health Canada approves Merit Medical Systems’ Wrapsody CIE device - Yahoo
What To Expect From ICU Medical’s (ICUI) Q1 Earnings - Yahoo Finance
Merit Medical Gets Approval From Health Canada for Wrapsody CIE - marketscreener.com
Merit Medical’s WRAPSODY CIE wins Health Canada approval By Investing.com - Investing.com India
Merit Medical’s WRAPSODY CIE wins Health Canada approval - Investing.com Canada
Merit Medical Systems Says Health Canada Approved Wrapsody Cell-Impermeable Endoprosthesis - Nasdaq
Merit Medical (MMSI) Gains Health Canada Approval for Innovative Stent Device | MMSI Stock News - GuruFocus
Merit Medical Announces Health Canada Approval of the WRAPSODY® - GuruFocus
Merit Medical Announces Health Canada Approval of the WRAPSODY® Cell-Impermeable Endoprosthesis - The Manila Times
Merit Medical Systems Announces Approval of WRAPSODY Cell-Impermeable Endoprosthesis in Canada for Hemodialysis Patients - Nasdaq
Breakthrough: Merit Medical's New Hemodialysis Device Shows 70% Success Rate, Receives Health Canada Approval - Stock Titan
Merit Medical reports positive WAVE trial results By Investing.com - Investing.com South Africa
Merit Medical (MMSI) Unveils Promising WAVE Trial Results at Symposium | MMSI Stock News - GuruFocus
Merit Medical reports positive WAVE trial results - Investing.com
Merit Medical Releases 12-Month Efficacy Results for the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY® Arteriovenous Efficacy (WAVE) Trial | MMSI Stock News - GuruFocus
Merit Medical Releases 12-Month Efficacy Results for the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY® Arteriovenous Efficacy (WAVE) Trial - The Manila Times
Merit Medical's Breakthrough WRAPSODY Device Exceeds Performance Goals in Major Clinical Trial - Stock Titan
Artivion (AORT) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance
Learn to Evaluate (MMSI) using the Charts - news.stocktradersdaily.com
Press Release Distribution & PR Platform - ACCESS Newswire
Strong Quarterly Results Lifted Merit Medical Systems (MMSI) in Q1 - Insider Monkey
Merit Medical Systems, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - Yahoo Finance
Merit Medical (MMSI) Price Target Slashed Amid Revised Earnings Guidance | MMSI Stock News - GuruFocus
Merit Medical Systems, Inc. (NASDAQ:MMSI) Q1 2025 Earnings Call Transcript - Insider Monkey
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Merit Medical stock target cut to $100 at Needham, retains Buy - Investing.com Nigeria
Merit Medical’s revenue up 9.8% to USD 355.4M in Q1 2025 - Medical Buyer
Merit Medical stock target cut to $100 at Needham, retains Buy By Investing.com - Investing.com South Africa
The Analyst Verdict: Merit Medical Systems In The Eyes Of 17 Experts - Benzinga
Merit Medical (MMSI) Faces Tariff Challenges Amid Margin Expansi - GuruFocus
MMSI Stock Declines Despite Q1 Earnings Beating Estimates, Margins Up - Yahoo Finance
Merit Medical outlines 2025 revenue growth of up to 10.2% despite tariff challenges - MSN
Merit Medical (MMSI) Target Price Adjusted Amid Tariff Concerns - GuruFocus
Merit Medical (MMSI) Maintains Outperform Rating Despite Adjusted Price Target | MMSI Stock News - GuruFocus
Merit Medical (MMSI) Price Target Cut by Wells Fargo Despite Str - GuruFocus
Merit Medical (MMSI) Price Target Revised by Piper Sandler to $1 - GuruFocus
Decoding Merit Medical Systems Inc (MMSI): A Strategic SWOT Insi - GuruFocus
Merit Medical (MMSI) Reports Strong Q1 2025 Results and Projects Robust Growth - GuruFocus
Merit Medical Reports First Quarter 2025 Results and Updates Full-Year Guidance - The Manila Times
Merit Medical Q1 2025 slides: Strong revenue growth overshadowed by lowered EPS guidance - Investing.com South Africa
Merit Medical: Q1 Earnings Snapshot - CTPost
Merit Medical Reports Strong Q1 2025 Results - TipRanks
Earnings call transcript: Merit Medical Q1 2025 beats earnings forecast - Investing.com
Finanzdaten der Merit Medical Systems Inc-Aktie (MMSI)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):